B Lindahl
Impact in
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Papers in
-
- Endometrial and Cervical Cancer Treatments 23
- Uterine Myomas and Treatments 4
- Genetics 15
- Estrogen and related hormone effects 15
- Co-authors
- Roger Wïllén (19 shared papers)Johannes Mair (2 shared papers)Yonathan Hasin (2 shared papers)Wolfgang Köenig (2 shared papers)Per Venge (2 shared papers)Christian W. Hamm (2 shared papers)Marcello Galvani (2 shared papers)Hugo A. Katus (2 shared papers)
In The Last Decade
B Lindahl
47 papers receiving 1.4k citations
B Lindahl's Hit Papers
Peers
Comparison fields: 5 of 82
- Obstetrics and Gynecology 422
- Reproductive Medicine 280
- Cardiology and Cardiovascular Medicine 639
- Radiology, Nuclear Medicine and Imaging 304
- Internal Medicine 43
Countries citing papers authored by B Lindahl
This map shows the geographic impact of B Lindahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Lindahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Lindahl more than expected).
Fields of papers citing papers by B Lindahl
This network shows the impact of papers produced by B Lindahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Lindahl. The network helps show where B Lindahl may publish in the future.
Co-authors
The 25 scholars most cited alongside B Lindahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | How to use high-sensitivity cardiac troponins in acute cardiac care Hit paper breakdown → | 2012 | 523 |
| 2 | 2011 | 197 | |
| 3 | Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. | 1996 | 118 |
| 4 | 2009 | 80 | |
| 5 | 2010 | 59 | |
| 6 | Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer. | 1983 | 34 |
| 7 | Prognostic value of flow cytometrical DNA measurements in stage I-II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion, and degree of differentiation. | 1987 | 32 |
| 8 | 2004 | 29 | |
| 9 | Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations. | 1987 | 28 |
| 10 | Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen. | 2001 | 23 |
| 11 | Identification of chorion villi in abortion specimens. | 1986 | 22 |
| 12 | 1994 | 21 | |
| 13 | Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment. | 1990 | 21 |
| 14 | Some aspects of prophylactic oophorectomy and ovarian carcinoma. | 1981 | 18 |
| 15 | 2009 | 14 | |
| 16 | Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years. | 1995 | 13 |
| 17 | 2002 | 12 | |
| 18 | Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion. | 1987 | 12 |
| 19 | Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients. | 1991 | 11 |
| 20 | 1984 | 11 |
About B Lindahl
B Lindahl is a scholar working on Obstetrics and Gynecology, Genetics, Reproductive Medicine, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (23 papers), Estrogen and related hormone effects (15 papers), Ovarian cancer diagnosis and treatment (13 papers), Cancer Genomics and Diagnostics (4 papers), Reproductive System and Pregnancy (4 papers), Cervical Cancer and HPV Research (4 papers), Uterine Myomas and Treatments (4 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Obstetrics and Gynecology (422 citations), Reproductive Medicine (280 citations), Cardiology and Cardiovascular Medicine (639 citations), Radiology, Nuclear Medicine and Imaging (304 citations) and Internal Medicine (43 citations). B Lindahl has collaborated with scholars based in Sweden and Denmark. Frequent co-authors include Roger Wïllén, Johannes Mair, Yonathan Hasin, Wolfgang Köenig, Per Venge, Christian W. Hamm, Marcello Galvani, Hugo A. Katus, Kurt Huber and Marco Tubaro. Their work appears in journals such as European Heart Journal, Gynecologic Oncology, American Journal of Obstetrics and Gynecology, Acta Obstetricia Et Gynecologica Scandinavica and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.